HOME >> BIOLOGY >> NEWS
Success or failure of antidepressant citalopram predicted by gene variation

A variation in a gene called GRIK4 appears to make people with depression more likely to respond to the medication citalopram (Celexa) than are people without the variation, a study by the National Institute of Mental Health (NIMH), part of the National Institutes of Health, has found. The increased likelihood was small, but when people had both this variation and one in a different gene shown to have a similarly small effect in an earlier study, they were 23 percent more likely to respond to citalopram than were people with neither variation.

The finding addresses a key issue in mental health research: the differences in peoples responses to antidepressant medications, thought to be based partly on differences in their genes. Some patients respond to the first antidepressant they attempt, but many dont. Each medication takes weeks to exert its full effects, and patients depression may worsen while they search for a medication that helps. Genetic studies, such as the one described here, may lead to a better understanding of which treatments are likely to work for each patient.

Results of the study are in the August issue of the American Journal of Psychiatry, reported by lead researcher Francis J. McMahon, MD, Silvia Paddock, PhD, of NIMH, and colleagues. Scientists from the National Human Genome Research Institute, the National Institute on Alcohol Abuse and Alcoholism, Mount Sinai School of Medicine, and University of Texas Southwestern Medical Center also contributed to the research.

Were moving steadily closer to being able to personalize treatments based on patients genetic variations. This is a crucial need for the millions of Americans who suffer from depression, said NIMH Director Thomas R. Insel, MD. New techniques have led to advances that would have been inconceivable a few years ago and are making individualized treatment an achievable goal.

The researchers studied DNA provided earlier by patients participating in a recently comp
'"/>

Contact: Susan Cahill
scahill@mail.nih.gov
301-443-4536
NIH/National Institute of Mental Health
1-Aug-2007


Page: 1 2 3

Related biology news :

1. Success rates for prostate cancer depend on experience of surgeon
2. Successful development of prototype assays
3. Successful lung cancer surgery not enough to break nicotine dependence in many smokers
4. Successful one year gene therapy trial for Parkinsons disease announced by Neurologix
5. Successful transplantation from pig embryos to mice
6. Success comes at a cost, even for phages
7. Successful cell engineering may lead to mad cow prevention, say researchers
8. Success tastes sweet for scientists
9. Successful test of single molecule switch opens the door to biomolecular electronics
10. High blood pressure, low energy -- a recipe for heart failure
11. Specific type of cell death may accelerate decompensated heart failure

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2020)... ... August 06, 2020 , ... Alucio™, a ... announce that Eric Chen and Jessica Wong have joined the company’s leadership team ... respectively. , Eric Chen heads development efforts for Alucio’s flagship product, Beacon, an ...
(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received ... innovations, CoreText™ and ProText™, making them the first Wharton’s jelly allografts to be assigned ... syringe. The company’s solutions are the first Wharton’s jelly allograft product to be recognized ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... II contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense ... to develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 30, 2020 , ... ... industry, today announced the release of its signature product called Beacon - ... (MSLs) and other field medical professionals. , Beacon helps MSLs streamline ...
(Date:7/18/2020)... ... July 16, 2020 , ... Medial ... early detection and prevention of high-burden diseases, and Centric Consulting, a business and ... organizations to utilize existing data in order to identify and prioritize patients for ...
(Date:7/10/2020)... ... 09, 2020 , ... In most research using the zebrafish ... formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over the ... using the zebrafish model to investigate the causes of leukaemia and its relationship ...
(Date:7/1/2020)... ... 29, 2020 , ... MedShift , a leading medical ... many obstacles created as a result of COVID-19. As a provider at the ... practices and medical manufacturers by expanding access to device offerings, technology services, and ...
Breaking Biology Technology:
Cached News: